Cargando…
Options for first line therapy of Hodgkin lymphoma
Autores principales: | Longley, Jemma, Johnson, Peter W.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617793/ https://www.ncbi.nlm.nih.gov/pubmed/31187527 http://dx.doi.org/10.1002/hon.2597 |
Ejemplares similares
-
Management of aggressive lymphoma in very elderly patients
por: Thieblemont, Catherine, et al.
Publicado: (2017) -
What's new in peripheral T‐cell lymphomas
por: Luminari, Stefano, et al.
Publicado: (2021) -
Should Response-Adapted Therapy Now Be the Standard of Care for Advanced Hodgkin’s Lymphoma?
por: Johnson, Peter, et al.
Publicado: (2017) -
Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors
por: Holtzman, Adam L., et al.
Publicado: (2019) -
Radiation Recall Dermatitis After the Use of Pralatrexate for Peripheral T-cell Lymphoma
por: Bhangoo, Ronik S., et al.
Publicado: (2018)